RT Conference Proceedings
T1 Randomized, open-label, phase II trial of dostarlimab (TSR-042), as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemo-radiation: ATOMICC study
A1 Oaknin, A.
A1 Iglesias, M.
A1 Alarcon, J. D.
A1 Villacampa Javierre, G.
A1 Gaba Garcia, L.
A1 Santaballa, A.
A1 Manso, L. M.
A1 Romero, I.
A1 Barretina Ginesta, M. P.
A1 Churruca, C.
A1 Garcia, Y.
A1 Sanchez, A. B.
A1 Marquina, G.
A1 Pardo, B.
A1 Redondo, A.
A1 Rubio, M. J.
A1 Gonzalez Martin, A.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/25336
UL https://hdl.handle.net/10668/25336
LA en
DS RISalud
RD Apr 4, 2025